Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

231 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
Koie T, Ohyama C, Hashimoto Y, Hatakeyama S, Yamamoto H, Yoneyama T, Kamimura N. Koie T, et al. Among authors: kamimura n. Int J Clin Oncol. 2013 Aug;18(4):724-30. doi: 10.1007/s10147-012-0447-z. Epub 2012 Jul 19. Int J Clin Oncol. 2013. PMID: 23011100 Clinical Trial.
Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.
Koie T, Ohyama C, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N. Koie T, et al. Among authors: kamimura n. Prostate Cancer Prostatic Dis. 2012 Dec;15(4):397-401. doi: 10.1038/pcan.2012.29. Epub 2012 Aug 14. Prostate Cancer Prostatic Dis. 2012. PMID: 22890389 Clinical Trial.
231 results